AEON Biopharma, Inc. (AEON) stock
AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.15−0.01 (-3.59%)
Close on Nov 13, 2026Market cap $7.63MP/E –Yield –
AEON Biopharma total assets
Total assets on the balance sheet at the end of each period.
AEON Biopharma's total assets was $5.91M at Jun 30, 2026. For fiscal 2025 it was $5.56M, up 77.0% from the year before. The highest annual figure on record is $276.95M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.56M | +77.0% |
| FY2024 | Dec 31, 2024 | $3.14M | -54.1% |
| FY2023 | Dec 31, 2023 | $6.85M | -36.5% |
| FY2022 | Dec 31, 2022 | $10.78M | -96.1% |
| FY2021 | Dec 31, 2021 | $276.95M | +341813.0% |
| FY2020 | Dec 31, 2020 | $81.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.91M | -49.3% |
| Q1 FY2026 | Mar 31, 2026 | $8.63M | -37.5% |
| Q4 FY2025 | Dec 31, 2025 | $5.56M | +77.0% |
| Q3 FY2025 | Sep 30, 2025 | $8.73M | +118.1% |
| Q2 FY2025 | Jun 30, 2025 | $11.66M | +103.4% |
| Q1 FY2025 | Mar 31, 2025 | $13.80M | +355.1% |
| Q4 FY2024 | Dec 31, 2024 | $3.14M | -54.1% |
| Q3 FY2024 | Sep 30, 2024 | $4.00M | -77.3% |
| Q2 FY2024 | Jun 30, 2024 | $5.73M | -73.7% |
| Q1 FY2024 | Mar 31, 2024 | $3.03M | -86.0% |
| Q4 FY2023 | Dec 31, 2023 | $6.85M | -36.5% |
| Q3 FY2023 | Sep 30, 2023 | $17.62M | -93.6% |
| Q2 FY2023 | Jun 30, 2023 | $21.79M | -92.1% |
| Q1 FY2023 | Mar 31, 2023 | $21.62M | -92.2% |
| Q4 FY2022 | Dec 31, 2022 | $10.78M | -96.1% |
| Q3 FY2022 | Sep 30, 2022 | $277.32M | +0.0% |
| Q2 FY2022 | Jun 30, 2022 | $276.51M | -0.4% |
| Q1 FY2022 | Mar 31, 2022 | $276.65M | -0.5% |
| Q4 FY2021 | Dec 31, 2021 | $276.95M | +341813.0% |
| Q3 FY2021 | Sep 30, 2021 | $277.20M | – |
| Q2 FY2021 | Jun 30, 2021 | $277.62M | – |
| Q1 FY2021 | Mar 31, 2021 | $278.15M | – |
| Q4 FY2020 | Dec 31, 2020 | $81.00K | – |
See a number that looks wrong?